Nanocaged enzymes with enhanced catalytic activity and increased stability against protease digestion.

Zhao Z, Fu J, Dhakal S, Johnson-Buck A, Liu M, Zhang T, Woodbury NW, Liu Y, Walter NG, Yan H. · 2016

Read Nanocaged enzymes with enhanced catalytic activity and increased stability against protease digestion. by Zhao Z, Fu J, Dhakal S, Johnson-Buck A, Liu M, Zhang T, Woodbury NW, Liu Y, Walter NG, Yan H. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4749968.txt.

Introduction

Zhao and nine colleagues mimic the cell's habit of boxing enzymes into compartments, this time using self-assembled DNA nanocages. The cages hold enzymes at controlled numbers and positions. This lets the team test how enclosure and the cage's charged surfaces affect common metabolic enzymes, in bulk and one molecule at a time.

Encapsulated enzymes turn over substrate faster than free ones. Oddly, smaller proteins gain more than larger ones, which the authors attribute to the cage's water layer stabilising active shapes. The cages also shield their cargo from protein-chewing enzymes, a practical virtue for biotechnology and functional biomaterials.

Catalog record

CREATORZhao Z, Fu J, Dhakal S, Johnson-Buck A, Liu M, Zhang T, Woodbury NW, Liu Y, Walter NG, Yan H.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4749968

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Nanocaged enzymes with enhanced catalytic activity and increased stability against protease digestion By Zhao Zhao, Jinglin Fu, Soma Dhakal, Alexander Johnson-Buck, Minghui Liu, Ting Zhang, Neal W. Woodbury, Yan Liu, Nils G. Walter, Hao Yan Published in: Nature Communications DOI: 10.1038/ncomms10619 ABSTRACT Cells routinely compartmentalize enzymes for enhanced efficiency of their metabolic pathways. Here we report a general approach to construct DNA nanocaged enzymes for enhancing catalytic activity and stability. Nanocaged enzymes are realized by self-assembly into DNA nanocages with well-controlled stoichiometry and architecture that enabled a systematic study of the impact of both encapsulation and proximal polyanionic surfaces on a set of common metabolic enzymes. Activity assays at both bulk and single-molecule levels demonstrate increased substrate turnover numbers for DNA nanocage-encapsulated enzymes. Unexpectedly, we observe a significant inverse correlation between the size of a protein and its activity enhancement. This effect is consistent with a model wherein distal polyanionic surfaces of the nanocage enhance the stability of active enzyme conformations through the action of a strongly bound hydration layer. We further show that DNA nanocages protect encapsulated enzymes against proteases, demonstrating their practical utility in functional biomaterials and biotechnology. Common micro- and nanoscale subcellular compartments are formed from either lipids or proteins and include mitochondria, lysosomes, peroxisomes, carboxysomes and other metabolosomes, as well as multi-enzyme complexes12345. Compartments increase the overall activity and specificity of the encapsulated enzyme pathways by maintaining a high local concentration of enzymes and substrates, promoting substrate channelling and protecting their content from damage, as well as by segregating potentially damaging reactions from the cytosol. Spatial confinement is also an important aspect for chaperone-assisted folding of linear polypeptides into active tertiary and quaternary conformations, as well as for preventing proteins from aggregating under cellular stress conditions6. A better understanding of the effects of spatial confinement on protein function will not only enhance our fundamental knowledge of cellular organization and metabolism but also increase our ability to translate biochemical pathways into a variety of noncellular applications, ranging from diagnostics and drug delivery to the production of high-value chemicals and smart materials7891011. Over the past few decades, artificial enzymatic particles have been created using compartmentalization by virus-like protein particles7, liposomes or polymersomes5 and chemical crosslinking8. However, severe obstacles to a broader application remain, including low encapsulation yield of large proteins because of steric hindrance12, insufficient access of substrates to the encapsulated enzymes, aggregation of vesicle shells13 and limited control over the spatial arrangement of proteins within the compartments710. Recently, DNA nanostructures have started to emerge as promising molecular scaffolds to organize biomolecules at the nanoscale based on their programmable, sequence-driven self-assembly14151617181920. For example, multi-enzyme cascades have been assembled on DNA nanostructures with precise control over the spatial arrangement to enhance catalytic activity by substrate channelling1921. Conversely, self-assembling DNA nanoboxes and -cages have shown promise in the delivery of macromolecular payloads such as antibodies2223 and enzymes24. Tubular DNA nanostructures have also been used to construct efficient enzyme cascade nanoreactors2526. Here, we describe a simple and robust strategy for the DNA nanocage-templated encapsulation of metabolic enzymes with high assembly yield and controlled packaging stoichiometry. With such an approach in hand, we sought to test the hypothesis that the recently described, chaperone-like stabilizing impact of polyphosphate on metabolic protein enzymes27 together with the cryptic RNA binding properties of many enzymes28 may lead to beneficial effects when enzymes are surrounded by DNA nanocages. RESULTS Enzyme encapsulation strategy As shown in Fig. 1a, our approach for enzyme encapsulation within DNA nanocages involves two steps: (1) the attachment of an individual enzyme into an open half-cage and (2) the assembly of two half-cages into a full (closed) nanocage. DNA half-cages were constructed by folding a full-length M13 viral DNA29 into the indicated shape based on a honeycomb lattice using the DNA origami technique14; a shape with two open sides was chosen to improve accessibility of the internal cavity to large proteins. Two half-cages were then linked into a full-cage by adding 24 short-bridge DNA strands that hybridize with the complementary ssDNA sequences extending from the edges of either half-cage. The DNA full-cage is ∼54 nm × 27 nm × 26 nm with designed inner cavity dimensions of 20 nm × 20 nm × 17 nm. By design, 42 small nanopores (each ∼2.5 nm in diameter) were introduced on each of the top and bottom surfaces of the DNA nanocage to permit the diffusion of small molecules (for example, enzyme substrates) across the DNA walls (Supplementary Fig. 1). The formation of half and full DNA nanocages was first characterized using transmission electron microscopy (TEM) (Supplementary Figs 2 and 3) and gel electrophoresis (Supplementary Fig. 4), which indicate a nearly 100% yield for half-cages and a more than 90% yield for full-cages. To capture target enzymes into a half-cage, a previously reported succinimidyl 3-(2-pyridyldithio) propionate (SPDP) chemistry was used to crosslink a lysine residue on the protein surface to a thiol-modified oligonucleotide193031. Two anchor probes of complementary sequence were displayed on the bottom of the half-cage cavity to capture a DNA-modified enzyme via sequence-specific DNA hybridization. As a demonstration of an enzyme cascade, a glucose oxidase (GOx)-attached half-cage was incubated with a horseradish peroxidase (HRP)-attached half-cage at a stoichiometric ratio of ∼1:1, followed by the addition of bridge strands into solution to assemble a full-DNA nanocage containing a GOx/HRP pair. The inner cavity of a full nanocage is of sufficient size to encapsulate this enzyme pair (GOx is ∼10 nm (ref. 32) and HRP ∼5 nm in diameter (ref. 33)). Unencapsulated enzyme and excess short DNA strands were removed using agarose gel electrophoresis29. Details of the enzyme–DNA conjugation and optimization of the assembly are discussed in Supplementary Figs 5–10, Supplementary Table 1 and Supplementary Note 1. Characterization of enzyme encapsulation To verify the presence of both enzymes within a DNA nanocage, the co-localization of a Cy3-labelled GOx (green emission) and a Cy5-labelled HRP (red emission) was quantified by dual-colour fluorescence gel electrophoresis, where a gel band with overlapped green and red colours was identified (see Supplementary Fig. 11). By comparison, the GOx-containing half-cage (Half[GOx]) shows the presence of only Cy3 (green), whereas a HRP-half-cage (Half[HRP]) shows the presence of only Cy5 (red). In addition, negatively stained TEM images were used to visualize DNA cages upon stoichiometrically controlled encapsulation of a single GOx (Fig. 1b) or a single GOx/HRP pair (Fig. 1c), where GOx and HRP were visible as brighter spots within the cage. To quantitatively analyse the yield of DNA nanocage encapsulation, two-colour total internal reflection fluorescence (TIRF) microscopy34 (Fig. 2a) was used to characterize the fluorescence co-localization of a Cy3-labelled enzyme and a Cy5-labelled nanocage (Fig. 2b). Six different enzymes were tested and characterized for encapsulation, ranging from the smallest HRP (∼44 kDa)35, (malic dehydrogenase (MDH, ∼70 kDa)36, glucose-6-phosphate dehydrogenase (G6PDH, ∼100 kDa)37, lactic dehydrogenase (LDH, ∼140 kDa)38 and GOx (∼160 kDa)39 to the largest β-galactosidase (β-Gal, ∼450 kDa)40. All six enzymes were successfully encapsulated within full DNA nanocages with high yields, ranging from 64 to 98% (Fig. 2c and Supplementary Table 2). The relatively low yield of β-Gal (64%) may be because of its large size (∼16 nm in diameter), which is comparable to the inner diameter of the nanocage (∼20 nm), likely resulting

Read the complete text